(Q43152304)

14 November 2017

Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study (English)

1 reference

14 November 2017

1 reference

1 reference

G A Garinis

1

1 reference

14 November 2017

B Fruci

2

1 reference

14 November 2017

A Mazza

3

1 reference

14 November 2017

M De Siena

4

1 reference

14 November 2017

S Abenavoli

5

1 reference

14 November 2017

E Gulletta

6

1 reference

14 November 2017

V Ventura

7

1 reference

14 November 2017

M Greco

8

1 reference

14 November 2017

L Abenavoli

9

1 reference

14 November 2017

A Belfiore

10

1 reference

14 November 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

International Journal of Obesity

14 November 2017

1 reference

14 November 2017

34

1 reference

14 November 2017

1255-1264

1 reference

14 November 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2010.40

14 November 2017

0 references

cites work

Hepatic steatosis in obese patients: clinical aspects and prognostic significance.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Metformin in the treatment of patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Liver fat in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Effect of weight control on hepatic abnormalities in obese patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Non-invasive diagnosis of steatosis and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

7 January 2021

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

7 January 2021

Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

7 January 2021

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.40

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.40

1 reference

Dimensions Publication ID

14 November 2017

0 references

1 reference